Indian doctor fined for professional misconduct in Singapore

Image
Press Trust of India Singapore
Last Updated : Jun 10 2015 | 9:07 AM IST
A 32-year-old Indian-origin doctor in Singapore has been fined Singapore dollars 2,000 for administrating a drug to a patient in wrong way at the Singapore General Hospital in July 2012.
The Singapore Medical Council (SMC) said Dr Garuna Murthee Kavitha injected the chemotherapy drug into the patient's spinal canal, rather than a vein. This could have caused the patient severe neurological damage, the Straits Times reported today.
In deciding on the sentence, the SMC's disciplinary tribunal took into consideration the fact that Kavitha, noticed the error immediately and she did not avoid responsibility.
It also noted that the ward at the SGH, where she was working at the time, had given her the wrong medicine which she did not check.
The doctor-in-charge ordered two chemotherapy drugs to be administered to the man who was admitted for a cancer relapse.
The drugs, Velcade was to be given intravenously and Methotrexate was to be injected into the spinal canal.
Kavitha, who was there to treat the patient, took the only syringe of Velcade in the room and injected into the man's spinal canal without checking the chemotherapy form which stated the medication should be injected into a vein.
On realising her mistake, she immediately called the senior doctor-in-charge.
In a statement released yesterday, SMC said it took note of the fact that Dr Kavitha was a young medical officer at the time. Her superiors, colleagues and the family of another of her patients testified to her strong work ethic and sense of responsibility.
The SMC's tribunal found her guilty of one charge of professional misconduct in April.
In the grounds of decision, the SMC also stated that a financial settlement was made between the doctor, the hospital, and the family members of the patient who had since died.
"We would like to reassure our patients that we have since reinforced our processes to prevent such a case occurring in future," said SGH medical board chairman Professor Fong Kok Yong.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 10 2015 | 9:07 AM IST

Next Story